From the Clinic
With health care workforce shortages still putting pressure on access and market transparency getting more attention, Direct Primary Care stands out as a model built around clarity.
Hypermobile Ehlers-Danlos syndrome (hEDS) is getting more attention right now because the conversation is shifting toward the full picture: genetics, POTS, MCAS, dysautonomia, chronic pain, digestive issues, and better care coordination.
Direct Primary Care is showing up in a bigger conversation right now because employers and patients are both looking for care that feels simpler, more affordable, and more personal.
Hypermobile Ehlers-Danlos Syndrome (hEDS) is getting more attention right now because more people are connecting the dots between hypermobility, POTS/dysautonomia, MCAS, chronic pain, brain fog, fatigue, and even hormone shifts like perimenopause and menopause.
At Nightingale Direct Care, we’re rewriting the healthcare experience. Our members enjoy an average of 35 minutes with their Provider per visit (yes, you read that right—35 minutes vs. the typical 13!).
Spravato (esketamine) is trending right now as more people look for faster, provider-guided options for treatment-resistant depression. Recent attention around rapid-acting mental health treatments, access to care, monitoring requirements, and insurance coverage is keeping esketamine in the conversation.
Direct Primary Care is showing up in a big way right now because patients and employers want something healthcare has been missing for years: simpler access, clearer pricing, and a more personal relationship with a provider.
Hypermobile Ehlers-Danlos Syndrome (hEDS) is showing up more in conversations because more people are finally connecting the dots between hypermobility, chronic pain, fatigue, brain fog, POTS/dysautonomia, MCAS, and the daily reality of living with a rare connective tissue disorder.
Spravato (esketamine) is still drawing attention as more people look for faster-acting options for treatment-resistant depression and broader mental health support.
Direct Primary Care is trending right now because patients and employers want healthcare that feels simpler, more affordable, and more personal.
Hypermobile Ehlers-Danlos Syndrome (hEDS) is getting more attention right now because more people are finally talking about the connection between hypermobility, chronic pain, fatigue, brain fog, POTS/dysautonomia, MCAS, and the daily reality of living with a rare connective tissue disorder.
Spravato (esketamine) is still one of the most talked-about mental health treatment options right now, and for good reason. Recent coverage around telepsychiatry, access to interventional care, and new depression research is keeping the spotlight on fast-acting treatments for people who have not found relief with standard options.
Direct Primary Care (DPC) is trending because more patients want simpler, faster, and more personal healthcare.
Hypermobile Ehlers-Danlos Syndrome (hEDS) is getting more attention right now because the conversation is shifting toward the full picture: hypermobility, chronic pain, fatigue, brain fog, POTS/dysautonomia, MCAS, and the daily reality of living with a rare connective tissue disorder.
While traditional insurance leaves millions behind, DPC is stepping up to provide accessible, high-quality primary care that puts the "care" back in healthcare.
If you've been searching for answers — chronic joint pain, frequent dislocations, easy bruising, POTS flares, or mast cell reactions that seem connected — you might be looking at Ehlers-Danlos Syndrome (EDS).
Unlike traditional antidepressants that can take weeks to show effect, Spravato works differently — targeting the brain's glutamate system to deliver **rapid relief** from severe depression symptoms.
New data just dropped:** ACA marketplace enrollment could drop by **5 MILLION people** this year as deductibles jump by **$1,000+** after subsidies expired. Many families are now paying $3,786+ before insurance even kicks in.
Hypermobile Ehlers-Danlos syndrome (hEDS) is part of the conversation right now for a reason: people are talking more openly about diagnosis delays, POTS and dysautonomia, MCAS, chronic pain, fatigue, and brain fog.
If you've tried traditional antidepressants but still feel stuck in a dark place, you're not alone — and there may be a new option worth exploring.
Spravato is an FDA-approved nasal spray specifically designed for adults living with **treatment-resistant depression
If antidepressants haven't given you the relief you deserve, you're not alone — and there's new hope. **Spravato** is an **FDA-approved nasal spray** treatment specifically designed for adults living with **treatment-resistant depression (TRD)** and **major depressive disorder (MDD)** with suicidal thoughts or actions.
A new KFF analysis just dropped a bombshell: nearly **5 million Americans** are projected to lose their ACA marketplace coverage this year, and those who stay are paying **$1,000 MORE in deductibles** than last year. Monthly premiums have jumped $65 on average.
A major Democratic think tank just proposed "FREE primary care for all Americans" ahead of the midterm elections. Their plan? Create a new "American Health Gateway" to make basic healthcare accessible and affordable.
New 2025 research is completely shattering the divide between mental and physical health for those living with Ehlers-Danlos Syndrome (EDS).
The Primary Care Enhancement Act (part of the One Big Beautiful Bill Act) took effect January 1, 2026, allowing Health Savings Account (HSA) funds to pay for Direct Primary Care memberships. This is the most significant policy change affecting DPC in recent years, with coverage across MedPage Today, MedCity News, KSL, Lexology, and multiple industry publications. The change removes a major barrier to DPC adoption and positions DPC as a mainstream healthcare option for millions with HDHP/HSA plans.
A September 2024 study identified a unique blood signature in hypermobile Ehlers-Danlos syndrome (hEDS) and Hypermobility Spectrum Disorder (HSD)—bringing us closer than ever to a definitive diagnostic tool.
If you've tried multiple antidepressants without relief, you know how frustrating it can be. Spravato (esketamine) offers a different approach.
Unlike traditional antidepressants that target serotonin, Spravato (esketamine) works uniquely on the NMDA receptor in your brain — part of the glutamate system that's believed to play a key role in mood regulation.
For millions of people living with Ehlers-Danlos Syndrome (EDS), the diagnostic journey has been nothing short of exhausting.
When traditional depression treatments haven't provided relief, Spravato (esketamine) may offer a different approach
When traditional antidepressants haven't provided relief, it can feel like there's nowhere left to turn. Spravato (esketamine) offers a different path forward
If you've been researching depression treatment options, you may have heard about Spravato (esketamine) – an FDA-approved nasal spray for treatment-resistant depression and major depressive disorder with suicidal thoughts. But what is the actual treatment experience like?
Starting January 1, 2026, Direct Primary Care memberships are officially HSA-eligible! This means you can use your Health Savings Account to pay for personalized, unlimited access to your clinician with tax-free dollars.
Ehlers-Danlos Syndrome (EDS) is a group of genetic connective tissue disorders that affect approximately 1 in 5,000 people worldwide. Despite its prevalence, the average diagnosis delay is an staggering 10+ years.
Heavy Menstrual Bleeding Affects 9 in 10 Women With Ehlers-Danlos Syndrome: New Study Exposes Critical Healthcare Gap
Starting this year, you can finally use your Health Savings Account (HSA) to pay for Direct Primary Care (DPC) memberships. That's right—your pre-tax dollars can now cover unlimited access to personalized healthcare.
The healthcare revolution is here—and it's about to hit the mainstream.
Living with treatment-resistant depression can feel overwhelming.
Big News for the EDS Community!
Groundbreaking Genetic Study Reveals Hidden Causes of Hypermobile EDS
Direct patient care is the cornerstone of the medical profession, involving face-to-face interactions like physical exams, medication administration, and emotional support.